Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.08), Zacks reports. The business had revenue of $12.05 million for the quarter, compared to analysts’ expectations of $12.22 million. During the same quarter […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Aquestive Therapeutics (NASDAQ:AQST – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $9.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 116.35% from the stock’s previous close. A number […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,320,000 shares, an increase of 28.2% from the February 29th total of 1,810,000 shares. Based on an average daily volume of 1,870,000 shares, the short-interest ratio […]
Wedbush reiterated their outperform rating on shares of Aquestive Therapeutics (NASDAQ:AQST – Free Report) in a research report released on Tuesday morning, Benzinga reports. Wedbush currently has a $4.00 target price on the stock. A number of other analysts have also commented on AQST. JMP Securities reissued a market outperform rating and issued a $8.00 […]